Aardvark Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AARD | VTVT | RNA | ALDX | ACRV | APLM | |
|---|---|---|---|---|---|---|
| Market cap | 97.39M | 120.44M | 140.44M | 54.64M | 81.42M | 62.15M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.9 | -6.5 | -1.0 | -3.3 | -1.2 | -32.8 |
| Price/book | 1.3 | 4.8 | 0.7 | 1.4 | 0.9 | -14.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −70.03% | +42.99% | −43.05% | −83.03% | +9.20% | +16.64% |
| Today | −6.51% | −2.31% | −2.26% | −1.15% | −0.52% | −0.84% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AARD news ›Aardvark Therapeutics Adds Veteran Independent Board Director
An announcement from Aardvark Therapeutics, Inc. ( (AARD) ) is now available. The most recent analyst rating on (AARD) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Aardvark Therapeutics, Inc.…
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Morningstar
AARDVARK DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and ... 15, 2026 (GLOBE NEWSWIRE) -- WHY:…
URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C.
AARD DEADLINE TUESDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
October 10, 2026 12:23 PM EDT | Source: The Rosen Law Firm PA SO WHAT: If you purchased Aardvark securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. AARD…
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Grabar Law Office is Investigating Claims on Your Behalf
October 10, 2026 10:00 ET | Source: Grabar Law Office Grabar Law Office PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who…
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
October 09, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC Bronstein, Gewirtz & Grossman, LLC NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm,…
AARD 4-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline - HBSS
October 09, 2026 18:12 ET | Source: Hagens Berman Sobol Shapiro LLP Hagens Berman Sobol Shapiro LLP SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in…
AARD UPCOMING DEADLINE: Levi & Korsinsky Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
Shares priced at $16.00 in the February 2025 offering closed at $4.57 on May 15, 2026, a decline of $11.43 per share, or 71.4%. The two-step slide included a $7.02 per-share drop (56.2%) to $5.47 and a later $2.16 per-share drop (32.1%).…
AARD Deadline: Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Download the Globe app to my phone or tablet NEW YORK--(BUSINESS WIRE)--Oct 7, 2026-- Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of Aardvark Therapeutics, Inc. (NASDAQ:…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
stocktitan.net22
-
prnewswire.com15
-
newsfilecorp.com11
-
globenewswire.com10
-
tigersroar.com4
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 99 articles, not a forecast.